JUNB and neoplasm: Importantly, disrupting the signaling between ERK2 and JUNB and Fos related antigen-1 transcription factors enabled vemurafenib-addicted tumor cells to survive on treatment discontinuation [95], suggesting the involvement of these transcription factors in developing tumor cell addiction to vemurafenib.